sera – Page 48 – Communicable Diseases Research

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Article

Published on 2021-08-052022-10-31
Journal: Cell [Category] COVID-19, MERS, SARS,

Seroprevalences of specific antibodies against avian pathogens in free-ranging ring-necked pheasants ( Phasianus colchicus ) in Northwestern Germany

Research Article

Published on 2021-08-042022-10-28
Journal: PLoS ONE [Category] Coronavirus,

Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series

Neurology

Published on 2021-08-042022-11-01
Journal: Frontiers in Neurology [Category] COVID-19,

[키워드] age antibody assessment associative Brazil cognitive Cognitive impairment COVID-19 COVID-19 symptoms CSF Drawing dysfunction Encephalopathies Encephalopathy evaluated examination Executive function female headache hypoxia IgA IgG IgG ELISA IgM/IgG individual Inflammation initial IQR median Mild Moderate COVID-19 Montreal neurologic Outpatient pathway Patient Peripheral blood positive reported respiratory symptom RT-PCR SARS-Co SARS-CoV-2 SARS-COV-2 infection screened sera serology Sery Seven state Subacute Swab Symptom syndrome Test tested the mean verbal Viral detection viral infection
[DOI] 10.3389/fneur.2021.678924 PMC 바로가기 [Article Type] Neurology

Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2

Medicine

Published on 2021-08-032022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] adaptive Adaptive immunity age analyzed available data Cell culture childhood children correlation COVID-19 cross-reactivity cultures death rates demonstrated Effect effective enzyme-linked immunosorbent epidemiological evaluated humoral immune response Immunity immunization immunized individual induce Infection inhibited lack less median median age National outbreak pathogenic pediatric polio Poliovirus poliovirus vaccine Population positive correlation presenting Prevalence Protein protocol RdRP RdRp protein response Retrospective study RNA-dependent RNA polymerase SARS-CoV-2 SARS-COV-2 infection sera serum severity symptomatic cases target vaccination Vaccinations Vaccine development Vero Cell
[DOI] 10.3389/fmed.2021.710010 PMC 바로가기 [Article Type] Medicine

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

SARS‑CoV-2 RBD219-N1C1: 효모 발현 SARS-CoV-2 재조합 수용체 결합 도메인 후보 백신은 마우스에서 바이러스 중화 항체 및 T 세포 면역을 자극합니다

Article

Published on 2021-08-032022-09-12
Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, 진단,

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model

Article

Published on 2021-08-032022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] 5′ UTR Antigen antigenic C-terminus Cell Cell-mediated immunity chimeric cytoplasmic demonstrated domain elicited exhibited expressed expressing Frame gene encoding hosts humoral immune response immunized increasingly infected cell Influenza Influenza virus inoculated MDCK cell Model mouse mucosal Neutralizing activity ORF passages peptide-based platform potent prime-boost regimen producing Protein Pseudotyped virus RBD response robust SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccine sera Seven single-cycle influenza virus-based vaccine spike RBD spike-pseudotyped virus the RBD the SARS-CoV-2 the vaccine Vaccine Vaccine development variants virus
[DOI] 10.3390/vaccines9080850 PMC 바로가기 [Article Type] Article

Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults

핀란드 어린이 및 성인에서 풍토성 코로나바이러스 OC43 및 229E 항체의 혈청유병률 및 SARS-CoV-2 교차 반응성

Article

Published on 2021-08-012022-09-11
Journal: Clinical immunology (Orlando, Fla.) [Category] MERS, SARS, 진단, 치료기술,

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening

거주 노인에서 mRNA 기반 COVID-19 백신 접종 후 항체 반응: 재개방에 대한 시사점

Article

Published on 2021-08-012022-09-11
Journal: Journal of the American Medical Directors Associat [Category] SARS, 치료기술,

[키워드] adaptive Adults advanced age All participant All participants Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibody antibody level antibody levels Antibody Response assisted living B.1.1.7 Beckman Coulter blinded calculated Care coefficients collected Community condition conducted correlated correlation COVID-19 COVID-19 vaccines criteria cross-sectional Descriptive statistics detectable evaluated Factor greater IgG immune response immune responses Immunity Immunoglobulin Impact impair independent independent living Long-term care magnitude males mounted mRNA mRNA-based mRNA-based COVID-19 vaccine Multiple linear regression multiple linear regression analysis neutralization titer neutralization titers nursing homes Older older adult participant Pearson correlation personal care personal care living Pittsburgh protective effect Protective effects provide pseudovirus pseudovirus neutralization titers. Quality improvement reflex reopening response risk SARS-CoV-2 SARS-CoV-2 pseudovirus sera setting Spearman Steroids use of steroids vaccination Variation
[DOI] 10.1016/j.jamda.2021.06.006 PMC 바로가기 [Article Type] Article

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

심장 이식 환자의 BNT162b2 백신 접종: 임상 경험 및 항체 반응

Article

Published on 2021-08-012022-09-11
Journal: The Journal of heart and lung transplantation : th [Category] 치료기술,

[키워드] adverse event adverse events allograft dysfunction Anti-RBD antibodies Anti-RBD antibody antibody Antibody Response BNT162b2 BNT162b2 vaccine characterized clinical conducted detectable dose doses dysfunction Efficacy Heart transplantation heart transplantation. IgG IgG response Immunocompromised Immunosuppressed individual injection injection site mycophenolic acid neutralized Neutralizing antibodies observation of BNT162b2 Pain Population Prospective Study pseudo-virus RBD Receptor-binding domain recipient recipients regimen rejection required SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose sera suggested the receptor-binding domain troponin vaccination Vaccine
[DOI] 10.1016/j.healun.2021.04.003 PMC 바로가기 [Article Type] Article

Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19

계절 인간 코로나바이러스 OC43에 대한 면역은 COVID-19의 치명적인 악화를 완화합니다

Article

Published on 2021-08-012022-09-11
Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 analysed antibody Antibody titre antibody titres cleavage cleavage site Clinical course Clinical data conserved coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus-2 correlation COVID-19 cross-reactive antibodies cross-reactive antibody cross-reactivity detect Deterioration develop disease Effect enzyme enzyme-linked immunosorbent assay epitope Epitopes fusion fusion peptide help human coronavirus human coronavirus OC43 Immunity immunogenic Immunosuppression Inpatient Inpatients investigated Mild mitigate not differ OC43 Outpatient outpatients patients with COVID-19 peptide peptides Pneumonia predict produced Prognosis respiratory S2ʹ cleavage site SARS-CoV-2 searched sera Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 severe cases Standard therapy titre with COVID-19
[DOI] 10.1016/j.ijid.2021.07.015 PMC 바로가기 [Article Type] Article